David Chivite

Associate Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Chivite is an Associate Professor at Universitat de Barcelona, Spain. His research focuses on the intersection of cardiovascular health and related co-morbidities, particularly in areas such as heart failure, chronic kidney disease, and diabetes. Recent publications include studies on sarcopenia, the effectiveness of telemedicine, and the application of machine learning in diagnosing heart failure. His work aims to enhance understanding and improve management strategies for patients with complex health issues.

Articles (15)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

MARIA QUERO RAMOS

associate professor

University of Barcelona

SPAIN

View details

Alicia Conde‐Martel

SPAIN

View details

Jesús Ribas Sola

Section Head

Hospital Universitari de Bellvitge

SPAIN

View details

Agnieszka Guligowska

Senior Research Specialist, Adjunct/Lecturer

Medical University of Lodz

POLAND

View details

Joanna Kostka

Medical University of Lodz

POLAND

View details

Vanesa Garces Horna

Profesor Asociado

Universidad de Murcia Facultad de Medicina

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Chivite

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Prevalence of Sarcopenia in chronic heart failure, and modulating role of Chronic Kidney Disease.

Machine learning for the development of diagnostic models of decompensated heart failure or exacerbation of chronic obstructive pulmonary disease

Musculoskeletal co-morbidities in patients with transthyretin amyloid cardiomyopathy: a systematic review.

Global approach to patients with heart failure: everything matters.

Diabetes and factors associated with cognitive and functional decline. The screening for CKD among older people across Europe (SCOPE) study.

Heart failure and cognitive impairment: Are we fully alert?,Insuficiencia cardíaca y deterioro cognitivo. ¿Estamos completamente alerta?

Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

[Sarcopenia and heart failure: Room for improvement in its knowledge].

Beta-blocker use in patients with heart failure with preserved ejection fraction and sinus rhythm.

Effectiveness of telemedicine in patients with heart failure according to frailty phenotypes: Insights from the iCOR randomised controlled trial.

Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness

No clear beneficial effects of beta-blockers for heart failure with preserved ejection fraction to improve prognostic outcomes in elderly patients with sinus rhythm.

[Is it important to know if octogenarians with heart failure have intermediate ejection fraction?]

Atrial fibrillation and cognitive impairment: some answers but many questions,Fibrilación auricular y deterioro cognitivo: algunas respuestas, pero muchas preguntas

Usefulness of systolic blood pressure combined with heart rate measured on admission to identify 1-year all-cause mortality risk in elderly patients firstly hospitalized due to acute heart failure

Collaborators (6)

MARIA QUERO RAMOS

Alicia Conde‐Martel

Jesús Ribas Sola

Agnieszka Guligowska

Joanna Kostka

Vanesa Garces Horna

Make your next move.